Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Galton, D.J.
Right arrow Articles by Ferns, G.A.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galton, D.J.
Right arrow Articles by Ferns, G.A.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 1999; 92: 223-232
© 1999 Association of Physicians

Commentary

Genetic markers to predict polygenic disease: a new problem for social genetics

D.J. Galton and G.A.A. Ferns1

From the Department of Human Metabolism and Genetics, St. Bartholomew's Hospital, London, and 1 Centre for Clinical Science & Measurement, School of Biological Sciences, University of Surrey, Guildford, Surrey, UK

Professor D.J. Galton, Department of Human Metabolism and Genetics, St Bartholomew's Hospital, London EC1A 7BE

Many genetic markers that relate to common multifactorial disease in adults have been identified during the past 15 years. Their use as adjuncts for the diagnosis, prognosis, prediction of disease or targeting therapy for these disorders has begun, good examples being the Factor V Leiden mutation for venous-thromboembolism, lipoprotein lipase mutations for hypertriglyceridaemia and the apolipoprotein E4 variant for Alzheimer's dementia. However, extensive gene–gene and gene–environment interactions make their use more complex than markers for the simpler monogenic disorders (such as cystic fibrosis, or Duchennne's muscular dystrophy). Possible misapplication of the genetic markers for multifactorial disease in the fields of risk prediction, direct sales to the public, life assurance, employment rights, and legislation for regulation of their use are discussed.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NeurologyHome page
M. R. Golomb, B. P. Garg, L. E. Walsh, and L. S. Williams
Perinatal stroke in baby, prothrombotic gene in mom: Does this affect maternal health insurance?
Neurology, July 12, 2005; 65(1): 13 - 16.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
M. Cushman
Inherited Risk Factors for Venous Thrombosis
Hematology, January 1, 2005; 2005(1): 452 - 457.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.